市场调查报告书
商品编码
1535200
全球心律调节器市场 - 市场规模(依细分市场)、占有率、监管、偿付、治疗、预测(~2033年)Pacemakers Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
本报告研究和分析了全球起搏器市场,提供了有关主要参与者、市场占有率、主要趋势、创新产品和技术以及竞争格局的资讯。
市场模型的主要内容如下。
已上市的心律调节器和不断变化的竞争格局
全球、区域和国家层面的特定市场考察
掌握包括医疗保健系统概述真实情况,促进市场了解。市场进入部分还提供有关偿付政策和监管环境的讯息,能够更深入地研究市场动态。
目标公司
Pacemakers Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.
A pacemaker is a device designed to regulate the beating of the heart by providing electrical impulses delivered by the electrodes contacting the heart muscle. A pacemaker can be a single chamber or dual chamber type.
Sick sinus syndrome also known sinus node dysfunction is a number of conditions causing arrhythmias. The major causes of sick sinus syndrome can be the failure of impulse generation, abnormal conduction or sinus node degradation. Heart block is an interruption or delay of electrical conduction from the atria to the ventricles due to conduction system abnormalities in the AV node or the His-Purkinje system. Heart block is classified into first degree, second degree and third degree heart block based on its severity. Sick node dysfunction, AV Block, and atrial fibrillation can be treated with antiarrhythmic medicines but a more reliable treatment is implantation of a cardiac pacemaker which helps in maintaining a regular heartbeat. Artificial pacemakers are well tolerated in elderly patients. Atrial based pacemakers are recommended for treatment of sinus node dysfunction and AV block in all the patients except those with chronic atrial fibrillation.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Pacemakers market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Medtronic Plc, Biotronik SE & Co KG, Abbott Laboratories, Boston Scientific Corp, MicroPort Scientific Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -